1. Reiter RJ. Melatonin: the chemical expression of darkness.
Mol Cell Endocrinol 1991; 79:C53–C58.
2. Ianas O, Olivescu R, Badescu I. Melatonin involvement in 23.
oxidative processes. Rom J Endocrinol 1991; 29:117–123.
3. Tan DX, Chen LD, Poeggeler B et al. Melatonin: a potent,
endogenous hydroxyl radical scavenger. Endocrine J 1993;
1:57–60. 24.
4. Reiter RJ. Oxidative damage in the central nervous system:
protection by melatonin. Prog Neurobiol 1998; 56:359–384.
5. Reiter RJ, Tang L, Garcia JJ et al. Pharmacological actions 25.
of melatonin in oxygen radical pathophysiology. Life Sci 1997;
60:2255–2271.
6. Hardeland R. New actions of melatonin and their relevance 26.
to biometeorology. Int J Bimetorol 1997; 41:47–57.
7. Blask DE, Sauer LA, Dauchy RT et al. Melatonin inhibition of cancer growth in vivo involves suppression of tumor
fatty acid metabolism via melatonin receptor-mediated signal 27.
transduction events. Cancer Res 1999; 59:4693–4701.
8. Tan DX, Manchester LC, Reiter RJ et al. Ischemia/reperfusion induced arrhytmias in isolated rat heart: prevention by 28.
melatonin. J Pineal Res 1998; 25:184–191.
9. Sewerynek E, Reiter RJ, Melchiorri D et al. Oxidative
damage in the liver induced by ischemia reperfusion: pro- 29.
tection by melatonin. Hepatogastroenterology 1996; 43:
898–905.
10. Cuzzocrea S, Costantino G, Mazzon E et al. Beneficial 30.
effects of melatonin in a rat model of splanchnic artery
occlusion and reperfusion. J Pineal Res 2000; 28:52–63.
11. Reiter RJ. The aging pineal and its physiological consequences. Bioessays 1992; 14:169–175. 31.
12. Pappolla MA, Sas M, Bick RJ et al. Melatonin prevents
death of neuroblastoma cells exposed to the Alzheimer amyloid peptide. J Neurosci 1997; 17:1683–1690. 32.
13. Acuna-Castroviejo D, Coto Montes A, Monti MG et al.
Melatonin is protective against MPTP-induced striatal and
hippocampal lesions. Life Sci 1997; 60:PL23–PL29. 33.
14. Carneiro RCG, Reiter JR. Melatonin protects against lipid
peroxidation induced by d-aminolevulinic acid in rat cerebel-
